March 8, 2018 / 6:26 AM / 6 months ago

BRIEF-Innate Pharma FY Net Results Swings To Loss Of 48.4‍​ Million Euros

March 8 (Reuters) - INNATE PHARMA SA:

* FY REVENUE AND OTHER INCOME EUR 44.0‍​ MILLION VERSUS EUR 65.7 MILLION YEAR AGO

* FY OPERATING LOSS EUR 40.0‍​ MILLION VERSUS INCOME EUR 7.6 MILLION YEAR AGO

* FY NET LOSS EUR 48.4‍​ MILLION VERSUS INCOME EUR 12.6 MILLION YEAR AGO

* CASH, CASH EQUIVALENTS AND FINANCIAL ASSETS AMOUNTED TO EUR 176.6 MILLION AS OF DEC. 31

* IPH5401 WILL ENTER FIRST CLINICAL STUDIES IN ONCOLOGY IN 2018

* EXPECTS CLINICAL READ-OUTS FOR BOTH MONALIZUMAB AND IPH4102 PROGRAM IN 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below